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Risk Factors for Pediatric Community-Acquired Methicillin-Resistant
Staphylococcus aureus
Melissa Gail Kessler
ABSTRACT
Methicillin-Resistant Staphylococcus aureus (MRSA) began as a nosocomial infec-
tion due to overuse of antibiotics. Several previous studies have reported an increase
in this infection in adult patients who have not been hospitalized. It has also been
reported that there is an increase in MRSA in children. Some of these children be-
came infected even though they were not at high risk for the infection. After approval
from the All Children’s Hospital Institutional Review Board (IRB), a cross sectional
study was conducted with pediatric admissions and pediatric emergency room visits
to determine the characteristics of Methicillin-Sensitive Staphylococcus aureus and
MRSA. During this study, a review of 672 medical charts was conducted. The study
participants ranged in age from newborns to 18 years of age. In order to be enrolled
in the study, the subjects’ cultures were collected either as outpatients or within
72 hours of admission. The data that was collected from each chart included age,
race/ethnicity, gender, type of infection, preexisting medical conditions, and risk fac-
tors for infection. The potential risk factors include antibiotic use, previous surgery
or outpatient procedure, previous MRSA infection, immunotherapy, community worn
device, and residence in a facility. Statistical analysis was conducted using Epi Info
and SAS software packages. In regards to demographic characteristics, black children
are 2.98 times more likely to have an MRSA infection than white children. Gender
and age were not risk factors for the development of the infection. The risk factors
that were significant in whites were home health care (OR= 6.12, CI= 5.16, 7.08),
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community worn device (OR= 2.28, CI= 1.67, 2.89), previous hospitalization (OR=
2.43, CI= 1.95, 2.91), previous MRSA infection (OR= 3.69, CI= 2.90, 4.48), and pre-
vious surgery (OR= 2.02, CI= 1.51, 2.53). In blacks, females were more likely to have
MRSA (OR= 2.57, CI= 1.73, 3.41). This finding may be due to the small sample size
of black children in the study. Of the analyzed risk factors, home health care (OR=
2.95, CI= 1.11, 4.79), community worn device (OR= 2.85, CI= 1.71, 4.01), previous
hospitalization (OR= 1.98, CI= 1.13, 2.83), previous surgery (OR= 2.79, CI= 1.79,
3.79), and previous antibiotic (OR= 5.60, CI= 4.66, 6.54) use were all significant risk
factors in blacks. Effect modification was tested between race and all risk factors.
Race was an effect modifier only for the risk factor of previous antibiotic use (pvalue
=.02). Adjustment of confounding was performed for each race due to the presence
of effect modification. After the adjustment for confounding in whites, only home
health care (OR=4.37 CI= 1.55, 12.32), previous MRSA infection (OR= 2.86 CI=
1.16, 7.05), and previous hospitalization (OR= 2.00 CI= 1.14, 3.50) remained statisti-
cally significant. In blacks, after adjustment of confounding, only previous antibiotic
use (OR= 5.13 CI= 1.75, 15.08) remained significant. Adjustment for confounding
was also preformed on the total risk factors model. A dose response relationship was
present with increasing risk factors present.
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CHAPTER 1
INTRODUCTION
In the past twenty years, there has been an increasing number of cases of Community-
Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA). Many studies have
been conducted on the adult population but very little attention has been paid to
the pediatric population. Of the studies that have been conducted, many found a
startling increase in CA-MRSA in children. Herold et al conducted a study comparing
the prevalence of pediatric CA-MRSA in August 1988-July 1990 to August 1993-July
1995 at The University of Chicago Children’s Hospital. [1] The study concluded that
the prevalence had risen from 10 per 100,000 in 1998-1990 to 259 per 100,000 in
1993-1995. [1] The predisposing risk factors for CA-MRSA noted in this study were
prolonged hospitalization, invasive or surgical procedures, indwelling catheters, en-
dotracheal tubes, and prolonged or recurrent exposure to antibiotics. [1] Sattler et al
also conducted a comparison of risk factors and clinical characteristics of CA-MRSA
in children and found that hospitalization of household contacts increased the risk of
MRSA infection. [2] Another risk factor that has been reported in the literature is
the association between parents and household contacts working in the health care
field and these infections. [2] It has also been noted that CA-MRSA infections are
more likely to be superficial skin infections then nosocomial MRSA infections. [1, 2, 3]
CA-MRSA can also be more easily treated because of their lack of resistance to non-
beta-lactam antibiotics when compared to nosicomially acquired isolates. [1]
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1.1 Purpose of the Study
This study was initiated as a result of the concerns expressed by the staff at All
Children’s Hospital to Roger Sanderson, Regional Epidemiologist for the Florida De-
partment of Health, about a possible increase in CA-MRSA at their institution. The
purpose of this study is to examine the cases of MRSA over a period of one and a
half years, 2002-2003 to perform epidemiologic analysis of children with Staphylococ-
cus aureus infections. The risk factors for infection will also be collected in order to
determine type of patient most likely to become infected. The information from this
study will be utilized to better assess patients upon entry to the hospital as to their
risk of harboring MRSA. This will also help the hospital prevent the spread of MRSA
to other patients.
1.2 Research Questions
1. Determine if the risk factors for MRSA in the adult population, identified in
previous studies, also apply to the pediatric population.
2. Determine which risk factors are more likely to predispose children to Methicillin-
Resistant Staphylococcus aureus infection.
3. Compare the demographic characteristics of children with MRSA to children
with Methicillin-Sensitive Staphylococcus aureus .
2
CHAPTER 2
HISTORY
Infection from Staphylococcus aureus was a serious cause of mortality before the ad-
vent of penicillin. It was recorded in the Iliad by Homer that 75% of wounded soldiers
died following their injuries and the most likely cause was infection. [4] It was also
recorded that 90-100% of amputations from 1870-1871 resulted in death during the
Franco-Prussian war. [4] During the Surgical Congress, in Berlin on April 9, 1880,
Alexander Ogston delivered a lecture on abscesses in which Staphylococcus aureus
was first described and illustrated. [4] He named them Staphylococcus because their
appearance in clusters looked like a bunch of grapes. [4] Staphyle means bunch of
grapes in Greek. Staphylococcus aureus is a gram positive cocci in the Micrococci
family and measures 0.5-1.5 microns in diameter. [5] In Ogston’s lecture he stated
that he recovered these cocci from nearly 100% of samples from acute abscesses from
varying parts of the body. [4]
After the introduction of penicillin, mortality due to Staphylococcus aureus in-
fections dramatically decreased. [4] However, resistance to penicillin soon began to
develop. [4] Methicillin was then introduced to treat infections caused by penicillin
resistant strains. [4] Then, in 1961, the first reports in Britian of methicillin resis-
tant strains began to surface and soon after, several countries were reporting similar
findings. [4, 6] In 1980 only 20% of Staphylococcus aureus strains were susceptible
to penicillin. Now Methicillin-Resistant Staphylococcus aureus (MRSA) is a global
problem in hospitals. [4]
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2.1 Transmission
MRSA infections may be acquired in several different ways. The most common way
is to be colonized by these strains. [7] Health-care workers are the most frequent
source of exposure for patients. [7] The health-care workers’ hands frequently be-
come transiently colonized with the bacteria from their own sources or through other
infected patients. [7] Patients may also become colonized or infected through other
various sources such as stethoscopes, bedding, bed rails, bedside tables, and other
environmental sources. [8]
2.2 Epidemiology
2.2.1 Seasonality
The rate of Staphylococcus aureus infections is constant throughout the year, therefore
Staphylococcus aureus does not show any seasonal trend. [4]
2.2.2 Age
Those most susceptible to infections caused by Staphylococcus aureus are those with
weaker immune systems. [5] With regard to age, the two populations with the weakest
immune systems are the very young and the elderly. [5] Neonatal infection usually
occur in the first several weeks after birth. [5] In the elderly, the infections are as-
sociated with increased exposure to various health-care settings including long-term
nursing home facilities. [5]
2.2.3 Geographic Distribution
Staphylococcus aureus infections are found worldwide. [4] Incidence of infection is
higher in areas associated with poverty where overcrowding is common and running
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water is scarce. [4] Clusters of infections have been documented in aboriginals in
Canada, New Zealand, and Australia. [4] A study was conducted between January
1997 and December 1999 where bloodstream isolates were recorded in various areas
of the world including the US, Canada, Latin America, Europe, and the Western
Pacific. [9] This study found that Staphylococcus aureus was found to be the most
prevalent cause of infection in all geographic regions. [9] The rates of MRSA in both
community and nosocomial isolates are steadily increasing. [9] In the US between 30-
40% of Staphylococcus aureus isolates were MRSA and the rate of MRSA in European
countries is about 25%. [9] The highest rates were found in the Asia-Pacific region
which included Taiwan, Singapore, Japan, and Hong Kong. [9] The rate of MRSA in
this region was greater than 60%. [9]
2.3 Underlying Medical Conditions
Several underlying medical conditions increase a person’s likelihood of becoming in-
fected with MRSA. The most important risk factor for becoming infected with MRSA
is to be colonized. [10] Of healthy adults, 30-50% are colonized, with 10-20% persis-
tently colonized. [7] Patients with type I diabetes, patients undergoing hemodialysis,
surgical patients, burn patients, and patients with HIV/AIDS are all at increased risk
for infection. [10] Patients with qualitative or quantitative defects in white blood cells
such as cancer and leukemia patients and transplant patients are also at risk. [7] Pa-
tients with chronic skin conditions and intravenous drug users are also at an increased
risk. [7, 11] This was first described in a Community-Acquired Methicillin-Resistant
Staphylococcus aureus (CA-MRSA ) outbreak in a Detroit hospital. [11] It is hypoth-
esized that the increased risk in due to the use of communal needles and sharing of
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other drug paraphernalia. [11] Intravenous drug users also tend to have poor hygiene
which increases their likelihood to be colonized by the bacteria. [11]
2.4 Clinical Features
Infections caused by Staphylococcus aureus can either be localized or systemic. This
depends on the degree of invasion and toxin production of the bacteria. Localized
infections are commonly known as abscesses. Systemic infections may include but
are not limited to bacteremia, endocarditis, osteomyelitis, and pneumonia. There are
also two toxigenic staphylococcal diseases: toxic shock syndrome and Staphylococcal
scalded skin syndrome.
2.4.1 Abscesses
Staphylococcus may invade the skin in several ways including wounds, follicles, or
skin glands. [5] The most common type of infection is folliculitis and hidradenitis. [5]
These infections are a mild, superficial inflammation of hair follicles or glands. [5]
These infections are usually self limiting but may progress to subcutaneous tissue
infections. [5] Furuncles or boils are a progression of folliculitis or hidradenitis to a
large red tender pustule. [5] These often occur in clusters, in friction bearing areas
of the body such as buttocks, breasts, axillae, and back of the neck. [5] Carbuncles
are an aggregation of a cluster of furuncles. [5] These infections are much larger
and more painful. [5] They usually appear on areas of thicker skin such as the back
of the neck. [5] This infection may progress to systemic disease. [5] Another type
of staphylococcal skin infection is impetigo. [5] This infection is characterized by
bubble-like epidermal swellings and may break and peel away. [5]
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2.4.2 Bacteremia
Bacteremia is defined as the presence of viable bacteria in the bloodstream. [7] The
bacteria gain entry to the bloodstream from any type of Staphylococcal infection in
which the body’s immune system cannot contain. [7] The mortality of Staphylococcal
bacteremia has remained between 11-43% over the past 15 years. [7] Factors associated
with increased mortality due to bacteremia are over 50 years of age, non-removable
foci of infection, and serious underlying cardiac, neurologic, or respiratory disease. [7]
Complications from bacteremia frequently occurs and the rate may be anywhere from
11-53 %. [7] Bacteremia caused by MRSA does not have an increase in mortality when
compared with Methicillin-Sensitive Staphylococcus aureus . [7]
2.4.3 Endocarditis
Endocarditis is the inflammation of the valves and lining of the heart. [7] The in-
cidence of endocarditis caused by Staphylococcus aureus has increased from 1981 to
1988 and may account for 25-35% of all endocarditis cases. [7] Some risk factors
for Staphylococcal endocarditis are being an intravenous drug user, elderly patients,
patients with prosthetic valves, and hospitalized patients. [7] Staphylococcus aureus
endocarditis differs in presentation from other endocarditis by its rapid onset, high
fever, and frequent involvement of normal cardiac valves. [7] In intravenous drug
users who develop endocarditis, the disease is most often found on the right side of
the heart. [7] The patients also tend to be younger and have a lower mortality rate
if not also infected with HIV. [7] In endocarditis, not related to drug use, the disease
is more often found in the left side of the heart and has a high mortality rate. [7]
The disease usually involves previously damaged valves. [7] Staphylococcus aureus is
one of the most common pathogens in nosocomial and prosthetic valve endocardi-
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tis. [7] Intravenous catheters are the most frequent source of bacterial inoculation. [7]
The mortality rate for nosocomial endocarditis regardless of pathogen is 40-56%. [7]
The rate may be even higher when the only pathogen taken into consideration is
Staphylococcus aureus. [7]
2.4.4 Osteomyelitis
Osteomyelitis is an infection of the vascular metaphysis of bones. [5] The bones that
are most commonly involved are the femur, tibia, ankle, or wrist. [5] Necrosis of bony
tissue and abscess formation lead to an elevated and tender lump. Osteomyelitis
occurs in two forms, primary and secondary. [5] Primary osteomyelitis is typically
seen in growing children, adolescents, and intravenous drug users. [5] Secondary or
traumatic osteomyelitis typically develops after a compound fracture or surgery in
cancer or diabetes patients. [5]
2.4.5 Pneumonia
Staphylococcus aureus can be aspirated into the lungs and cause pneumonia because
the bacteria frequently colonizing the nasopharynx. [5] The fatality rate is 50% even
though Staphylococcus aureus accounts for only a very small proportion of pneumonia
cases. [5]
2.4.6 Toxic Shock Syndrome
Toxic Shock Syndrome came into prominence in 1980-1981, when numerous cases
were associated with in introduction of super absorbent tampons. [7] The disease
had a fulminant onset and was often seen in previously healthy females. [7] Toxic
Shock Syndrome does not develop from a site of colonization and is not always asso-
ciated with menstruation. [7] In fact, a third of all cases are non-menstrual. [7] The
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non-menstrual cases are associated with localized infections from surgery or insect
bites. [7] Toxic Shock Syndrome toxin I is present in 90% of Toxic Shock Syndrome
menstrual cases, however other Toxic Shock Syndrome toxins have been associated
with nonmenstrual cases. [7] Patient with nonmenstrual Toxic Shock Syndrome have
a higher mortality rate than those associated with menstruation. [7]
2.4.7 Staphylococcal Scalded Skin Syndrome
Staphylococcal Scalded Skin Syndrome is commonly seen is children with infections of
the umbilical stump or eyes. [5] These infections lead to toxemia and when the toxin
reaches the skin it induces a painful bright red flush over the entire body. [5] The skin
then blisters followed by desquamation of the epidermis. [5] The majority of cases
have been described in infants and children under age four. [5] Exfoliative toxin is the
toxin that is responsible for this infection. [5] This toxin also causes Staphylococcal
impetigo which can affect all ages. [5]
2.5 Microbiology
Staphylococci can be isolated from pus, tissue exudates, sputum, urine, and blood. [5]
These specimens are then inoculated onto sheep or rabbit blood agar. [5] The colonies
that grow if Staphylococcus aureus is present in the specimen are large, round, and
opaque. [5] The bacteria grows best at 37 degrees Celsius and is a facultative anaer-
obe. [5] This means the bacteria’s growth is enhanced in the presence of oxygen and
carbon dioxide. [5] The bacteria can withstand high salt contents, extremes in pH,
and high temperatures. [5] It can also remain viable after months of air drying in ad-
dition to being resistant to many disinfectants. [5] These characteristics have allowed
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the organism to continue to plague the health-care system despite improvement in
both public health and health-care.
When a gram stain is performed on Staphylococcus aureus colonies it stains gram
positive and may be observed in irregular clusters. [5] Gram stain alone is not enough
to confirm the presence of Staphylococcus aureus . [5] The bacteria will be tested
for the presence of catalase which differentiates it from Streptococci which lack the
enzyme. [5] Staphylococci are differentiated from Micrococci by their ability to grow
anaerobically and to ferment sugars. [5] After the genus Staphylococcus has been
confirmed, a coagulase test is performed. [5] Staphylococcus aureus is the only species
of Staphylococci to produce coagulase, therefore, the presence of the enzyme confirms
a positive culture for Staphylococcus aureus. [5]
2.6 Antibiotic Resistance
Shortly after the introduction of penicillin, resistant strains to the antibiotic were
noted. Despite the presence of the antibiotic, the bacteria continued to grow. The
bacteria had adapted to its new treatment by producing β lactamase or penicillinase.
This enzyme inactivates the penicillin by hydrolyzing the β-lactam ring in its struc-
ture. [7] This enzyme is inducible and is often coded for in plasmids. [7] Today, less
than 5% of Staphylococcus aureus isolates are sensitive to penicillin. [7]
Other antibiotics, such as methicillin, were created to overcome the presence
of β-lactamase. [7] After the introduction of methicillin and other similar antibi-
otics, resistance was also noted. Resistance to methicillin confers resistance to all
penicillinase-resistant penicillins and cephalosporins. [7] This resistance requires the
mec gene which encodes for penicillin-binding protein 2a. [7] Penicillin-binding pro-
teins are membrane bound enzymes that become altered with the presence of the mec
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gene. [7] The penicillin-binding proteins are the targets of the β-lactam antibiotics. [7]
Without the mec gene these antibiotics have a high affinity for the penicillin-binding
proteins. [7] With the introduction of the mec gene the bacteria produces modified
penicillin-binding proteins which have a lower affinity for the antibiotic. [7]
2.7 Pathogenic Mechanisms
Staphylococcus aureus is a common organism that can be found as part of a person’s
normal flora. [7] It can colonize various areas of the body including the nares, axillae,
vagina, pharynx, and damaged skin. [7] Staphylococcus aureus can remain colonized
on a person indefinitely without causing any problems. [7] Only when the organism
is introduced into surrounding tissues or the bloodstream through a break in the skin
or mucous membrane, may a problem arise. [7] The infection may remain contained
in one area or disseminate depending on the individuals defense mechanisms. [7] The
presence of intravenous devices and urinary catheters increases the risk of infection. [7]
The pathogenicity of Staphylococcus aureus is caused by several enzymes and tox-
ins. The principle enzymes that are documented are catalase, coagulase, hyaluronidase,
and β-lactamase. The principle toxins are hemolysins, exotoxins, and exfoliative
toxin.
2.7.1 Enzymes
Catalase: All Staphylococci species produce catalase. [5] This enzymes breaks down
hydrogen peroxide into water and oxygen. [5] Hydrogen peroxide is used by neu-
trophils during phagocytosis. [5] The neutrophils uses hydrogen peroxide to form
toxic oxygen radicals. [5] The presence of catalase counteracts this mechanism. [5]
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Coagulase: Only Staphylococcus aureus species produce coagulase. [5] This enzyme
coagulates plasma and blood and causes fibrin to surround the bacteria and protect
it from the host defenses. [5] The enzyme also promotes adherence to tissues. [5]
Hyaluronidase: This enzyme is also known as the spreading factor. [5] It digests the
intracellular glue or hyaluronic acid that binds the connective tissue in the host. [5]
β-Lactamase: This extracellular enzyme opens the β-lactam ring of penicillin based
antibiotics. [5]
2.7.2 Toxins
Hemolysins: This group of toxins causes the lysis of red blood cells. [5] There are four
different types of this toxin α, β, γ, and δ. [5] α-toxin is the strongest hemolysin. [5]
As well as lysing red blood cells it also damages leukocytes, and skeletal muscle, and
heart and renal tissue. [5] β-toxin degrades sphnogomyelin and effects red blood cells,
leukocytes, and fibroblasts. [5] γ-toxin lyses red blood cells but the mechanism is
unknown. δ-toxin acts as a detergent disrupting biologic membranes. [5]
Exotoxins: The two most important exotoxins are leukocidin and enterotoxin. [5]
Leukocidin damages the cell membrane of macrophages and neutrophils and is another
way to inhibit the phagocytic host defense. [5] Enterotoxins act on the gastrointestinal
tract of humans to produce diarrhea. [5]
Exfoliative Toxin: This toxin separates the epidermal layer of the skin from the
dermis causing it to peel away. [5] It is responsible for Staphylococcal Scalded Skin
Syndrome, in which the skin appears burned. [5]
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2.8 Immunologic Response
Staphylococcus aureus invades the host by a break in the skin or mucous mem-
brane. [7] Once invasion takes place the host responds by activating the neutrophils
and macrophages. [7] The complement system also plays a role in the host defenses. [7]
There are several components in the cell wall of Staphylococcus aureus that activate
the complement system. [7] One of these components is peptidoglycan which acti-
vates the alternative complement pathway which results in the release of C3a and
C5a, as well as activation of neutrophils, macrophages, and natural killer cells. [7]
After the bacteria is coated with complement, the macrophages attaches. [7] During
phagocytosis, the bacteria is exposed to oxygen radicals. [7] This leads to a decrease
in pH and then the lysosomal enzymes become effective. [7] This, along with lactofer-
rin, are another means of the intracellular mechanism. [7] Humoral and cell mediated
responses are launched in addition to intracellular killing. [7]
2.9 Treatment
Abscesses must be surgically perforated and cleared of pus and foreign bodies. [7]
Severe systemic infections respond slowly and require intensive and lengthy oral
or injected therapy. [7] Penicillin is still the drug of choice if the isolate is sensi-
tive. [7] Semi-synthetic penicillins are preferred if β-lactamase production is demon-
strated. [7] If the patient has an allergy to penicillin, cephalosporins are used. [7] If
MRSA is recovered vancomycin, fluoroquinolones, trimethoprim-sulphamethoxazole,
clindomycin, or minocycline may be utilized. [7] There are several other antimicrobial
combinations that may be utilized to increase bacteriocidal activity or prevent the
development of resistance. [7] Therapy for invasive, life threatening infections is four
13
weeks or longer. [7] If the infection is originating from an indwelling device, removal
is suggested when possible. [7]
2.10 Prevention
It is impossible to prevent all colonizations and infections as long as humans are the
bacteria’s primary reservoir. The best way to prevent the spread of any bacteria is
handwashing. [12] Healthcare workers and family members need to be educated on
the proper handwashing techniques. [12] APIC guidelines specify that hands should
washed for at least 10 seconds before leaving a patient’s room regardless if gloves
are worn or not. [13] SHEA guidelines also indicate that when there is no visible
contamination of gloves with blood or body fluids that alcohol based hand rubs with
emollient may be used. [14]
Contact precautions should be practiced on all cases of MRSA . [12] Patients on
contact precautions should have a private room. [12] Contact precaution guidelines
specify that you should wear gloves and gowns upon each entry to the patient’s
room for all direct patient care. [12] SHEA guidelines suggest however, that gloves
and gowns should be worn even if there will only be contact with the environmental
surfaces of an infected patients room. [14] The gowns should be removed before leaving
the patients room in order to prevent the spread of MRSA to other patients. [12]
Patient care equipment should be dedicated to a single patient to prevent the spread
of the bacteria as well. [12] All hospital personnel should have annual continuing
education on patient care and basic infection control practices. [12] Patients should
not share food or drinks and all personal items should be thoroughly disinfected before
sharing with other patients or family members. [12]
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CHAPTER 3
LITERATURE REVIEW
Methicillin-Resistant Staphylococcus aureus (MRSA) was first isolated in 1961 in the
United Kingdom. [15] This was one year after methicillin was introduced as a treat-
ment for Staphylococcus aureus . [15] Then MRSA slowly disseminated until it began
causing serious hospital infections in the 1970’s. [15] MRSA has become increasingly
prevalent in nursing homes, rehabilitation facilities, and now even in the commu-
nity. [15]
Methicillin resistance is conferred by the SCCmec gene. [15] There are four genetic
classes of the mec gene. [15] It is hypothesized that type I SCC mec was present in
the first strains of MRSA that were isolated in the 1960’s. [15] Type I SCC mec
does not contain any other antibiotic resistance genes. [15] Type II and type III
SCC mec contain multiple resistance genes. [15] These types became prominent in
the 1980’s in nosocomial isolates. Type IV SCC mec is commonly isolated from
community acquired cases. [15] This type only encodes for methicillin resistance. [15]
It is susceptible to many other non-β-lactam antibiotics. [15] Type IV SCC mec has
been isolated from many countries including Japan, France, and Australia which
demonstrates the international dissemination of type IV SCC mec. [15]
The majority of literature discusses risk factors for the acquisition of MRSA . Some
of the most common risk factors are previous hospitalization, especially in intensive
care units or burn units, preceding antimicrobial therapy, and surgical procedures. [16,
17, 18, 19, 1, 3, 20, 21] Some studies have also noted intravenous drug use and nursing
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home residence as risk factors. [16, 17, 18, 19] In the pediatric population, day care
attendance and having a family member hospitalized within the past six months are
noted as potential risk factors. [2, 22, 19, 1, 3, 20]
3.1 Previous Studies
There have been several outbreaks of Community-Acquired Methicillin-Resistant Staphy-
lococcus aureus (CA-MRSA ) noted in the United States. The first of these was re-
ported by Rathore and Kline in 1989. [23] There were two cases of serious MRSA
infections in children who lacked any prior history of serious medical or surgical ill-
ness, antibiotic therapy, or hospitalization. [23] The first case was an eight year old
boy with osteomyelitis of the left calcaneus. [23] The second case was a ten month
old girl with bacteremia. [23] Both children had parents that were healthy and denied
intravenous drug use or contact with of any family member with health-care workers
or health-care facilities. [23]
The Centers for Disease Control and Prevention has also released several reports
of CA-MRSA . There were four pediatric deaths in Minnesota and North Dakota. [24]
The first case was a seven year old girl with an infected right hip joint. MRSA was
isolated from the blood, hip joint, and sputum. [24] The girl had no recent hospital-
izations and no family members with any contact with nursing homes or health-care
settings. [24] The second case was a sixteen month old girl with a prior otitis media
infection. [24] The organism was isolated from her blood and spinal fluid. [24] She also
had no predisposing risk factors. [24] The third case was a thirteen year old girl with
no predisposing risk. [24] MRSA was isolated from her blood, sputum, and pleural
fluid. [24] The last case was a twelve month old boy whose sister was treated for an
MRSA abscess. The organism was recovered from the boy’s pleural fluid and post
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mortem blood. [24] The isolates of the brother and sister were identical. [24] All of
the MRSA isolates in these four cases susceptible to all antimicrobial agents except
β-lactams. [24]
There were also three community outbreaks of skin infections associated with
MRSA in Los Angeles County in 2002. [25] The first outbreak was from two athletes
on the same wrestling team. [25] The second outbreak was reported by two large
infectious disease clinical practices who had an increase in MRSA in homosexual
men. [25] The last outbreak was reported by the Los Angeles County jail. [25] Each
of these outbreaks had similar antimicrobial susceptibility patterns and were all the
same predominant strain. [25]
The last reported outbreak of MRSA in the community was food-borne. [26] This
outbreak was linked to a food handler, food specimens, and three ill patrons. [26] This
was the first report of an outbreak of gastrointestinal illness caused by CA-MRSA
. [26]
There have been two prevalence studies conducted on adults concerning commu-
nity colonization by MRSA . Both of these studies were performed in the United
Kingdom. The first was conducted by Abudu et al using a random sample of adults
residing in Birmingham, UK in 1998. [27] The sample was randomly selected from
the survey practices list on the Health Authority population register using random
number sequences. [27] The participants had to be over the age of sixteen and nurs-
ing home residents were excluded. [27] Swabs of the anterior nares were taken. [27]
Common culture and antimicrobial susceptibility testing practices were utilized. [27]
The participants also completed a questionnaire which assessed information about
risk factors for the acquisition of the organism. [27]
The response rate was 58%. [27] Females comprised 60% of the sample and minor-
ity ethnic groups made up 8% of the sample. [27] Staphylococcus aureus was obtained
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from 63 isolates, which is a prevalence of 23%. [27] MRSA was isolated from 4 of the
63 isolates which is a prevalence of 1.5%. [27] No significant difference was found be-
tween any of the participants from which Staphylococcus aureus was isolated. [27] All
of the MRSA isolates that were recovered were consistent with the prevalent strain
in Birmingham hospitals. [27] This suggests that these isolates were more likely to be
associated with carriage of hospital-acquired strains in the community rather than
transmission within the community. [27] This study had several limitations resulting
from sampling bias. [27] This was due to a poor response rate, small sample size, and
a higher proportion of subjects over sixty five than in the general population. [27]
The second prevalence study that was preformed in the United Kingdom was
by Grundmann et al who investigated the prevalence of nasal carriage of MRSA in
a sample of people aged sixty five and over. [28] These participants all resided in
their own homes in the greater Nottingham Health District. [28] The sample size was
962. [28] Samples were taken from the anterior nares and demographic characteristics
and risk factor data was also collected from the participants. [28] Staphylococcus
aureus was isolated from 257 participants, eight were MRSA. [28] The population
prevalence was eight per thousand. [28] MRSA was associated with hospital admission
in the past six months and diabetes. [28] The presence of chronic skin ulcers was a
strongly associated confounder with MRSA and previous hospital admissions. [28]
All MRSA isolates were indistinguishable from the clone of MRSA was prevalent in
English hospitals. [28]
There were several medical chart reviews that were preformed in various hospitals
on adult CA-MRSA patients. The first chart review was preformed by Morin and
Hadler. They did a retrospective review of all persons admitted with Staphylococcus
aureus bacteremia in 1998, in four Connecticut metropolitan areas. [29] The purpose
of this study was to analyze the magnitude and epidemiology of community-onset
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Staphylococcus aureus and MRSA . [29] The four metropolitan areas comprised forty-
one towns with a total population of over one million and included nine acute-care
hospitals. [29] The medical charts of patients with Staphylococcus aureus bloodstream
infections during 1998 were analyzed. [29] The information extracted from the charts
was the town of residence, age, sex, race/ethnicity, date of admission and discharge,
date of culture, outcome infection, antibiotic susceptibility, hospitalization history,
iatrogenic risk factors for bacteremia, and underlying illnesses. [29] The study pop-
ulation was one hundred ninety two patients with community-onset bacteremia. [29]
The overall incidence of infection was 17/100,000. [29] The highest incidence of infec-
tion were among males, adults over sixty five, blacks, and residents of urban areas. [29]
MRSA was found in 15% of infections which made the overall incidence of community-
onset MRSA bacteremia 2.5/100,000. [29] Healthcare associated infections accounted
for the majority of bacteremia. [29] Of all community-onset Staphylococcus aureus,
only 6% had community-onset with no underlying medical conditions. [29] The overall
case-fatality rate for MRSA was 14%. [29] The main limitation of the study was that
the only infection under consideration was bacteremia. [29] There was also no infor-
mation on outpatient antibiotic use and no molecular method was used to compare
nosocomial to community strains. [29]
Salmenlinna et al conducted a study to estimate the proportion of CA-MRSA. [30]
The analysis was conducted on previous hospitalizations for all MRSA positive per-
sons in Finland from 1997-1999. [30] A comparison of MRSA isolates in persons with
and without hospital contact in terms of strain type, antibiotic resistance, and mec
determinant profile. [30] Data was obtained from the National Hospital Discharge
Register. [30] The records contained the date, the specimen source, patient date of
birth, sex, and place of treatment. [30] Phage typing, pulse field gel electrophoresis,
and antimicrobial drug susceptibility were also recorded. [30] There were five hundred
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and twenty MRSA isolates in Finland during that period. [30] The annual incidence
ranged from 2.3/100,000-4.1/100,000 and the proportion of CA-MRSA isolates was
21%. [30] Three strain types were identified that were associated with community
acquisition and none of these strains were multi-resistant. [30] Children were found to
be more likely to have CA-MRSA . [30] The limitations of the study were that some
MRSA could have been isolated from nursing home residents. [30] These cases should
have been classified as health-care-associated. [30] Also, local sample policy differences
may have affected the number and type of CA-MRSA identified. [30] Sampling and
screening policies in the community setting are not specified in the national guidelines
for MRSA prevention in Finland. [30] These guidelines are primarily directed for use
in a hospital setting with nosocomial infections as their focus. [30] Thirdly, no clinical
and risk factor data was collected besides previous hospitalization. [30]
The last chart review of adults was conducted by Johnson et al. [17] They con-
ducted a review of CA-MRSA cases of bacteremia and evaluated the risk factors and
epidemiology. [17] This was a case control study comparing MRSA to Methicillin-
Sensitive Staphylococcus aureus bacteremia at a 600 bed urban academic medical
center. [17] The charts of the participants were reviewed to collect data regarding un-
derlying conditions, sources of bacteremia, microbiology, patient outcomes, previous
hospitalizations, and antibiotic susceptibility. [17] The cases and controls were simi-
lar in all aspects except that the patients with MRSA bacteremia was more likely to
have presented from a long-term care facility and to have multiple admissions within
the preceding year. [17] This study concluded that the majority of CA-MRSA bac-
teremia was health-care-associated and occurred in patients with underlying medical
conditions. [17]
Tambyah et al conducted a study assessing the frequency of CA-MRSA infections
at a teaching hospital in Singapore. [18] The study was prospective in nature, collect-
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ing data for MRSA isolates from January to December 1998. [18] The prevalence of
Community-Acquired Methicillin-Resistant Staphylococcus aureus was 43%. [18] The
majority of infections were of the skin and soft tissue. [18] Of all of the Community-
Acquired infections, all but one case had been exposed to outpatient centers, visiting
nurses, or community hospitals. [18] The antibiotic resistance patterns in CA-MRSA
were similar when compared with nosocomial isolates. [18] This study demonstrated
that many presumed CA-MRSA infections are truly health-care associated due to the
increase in health-care in outpatient settings. [18]
Some studies have been conducted on the pediatric population. Among these are
several chart reviews. The most well documented of these was conducted by Herold et
al. The purpose of this study was to determine whether CA-MRSA infections in chil-
dren with no predisposing risk factors was increasing. [1] The study also defined the
spectrum of disease associated with MRSA isolation when compared to Methicillin-
Sensitive Staphylococcus aureus infections. [1] The study described the epidemiology
of CA-MRSA among hospitalized children in four ways. [1] A comparison of the
prevalence of CA-MRSA with identified risk in two time periods 1988-1990 and 1993-
1995. [1] A comparison of the proportions of infecting versus colonizing isolates was
conducted for the two time periods. [1] A third comparison of the clinical spectrum of
disease for infecting isolates in 1993-1995. [1] The infecting isolates were split into five
categories: CA-MRSA with identified risk, CA-MRSA without identified risk, nosoco-
mial MRSA, Community-Acquired Methicillin-Sensitive Staphylococcus aureus, and
nosocomial Methicillin-Sensitive Staphylococcus aureus. [1] A fourth comparison of the
three MRSA groups susceptibilities to other antibiotics was also conducted. [1] The
prevalence of of CA-MRSA without identified risk factors increased from 10/100,000
admissions in 1988-1990 to 250/100,000 admissions in 1993-1995. [1] Clinical disease
was associated with 43% of Community-Acquired isolates from children with iden-
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tified risk and 37.5% of nosocomial isolates were associated with clinical disease in
1988-1990. [1] In contrast, in 1993-1995, 80% of Community-Acquired isolates from
children with identified risk and 88% of Community-Acquired isolates from children
without identified risk, and 71% of nosocomial isolates were associated with clinical
disease. [1] In addition, comparing the clinical spectrum of disease, the distribution
of clinical syndromes associated with CA-MRSA in children with identified risk was
similar to that of children with nosocomial acquired disease. [1] The clinical spectrum
of disease for CA-MRSA without identified risk was very different. [1] Bacteremia
was associated with nosocomial and CA-MRSA with identified risk. [1] Abscesses are
more commonly seen in CA-MRSA without identified risk. [1] The disease association
rate for Community-Acquired Methicillin-Sensitive Staphylococcus aureus is similar
to CA-MRSA as well as the distribution of clinical syndromes. [1] With regards to
antibiotic susceptibility, isolates from children with CA-MRSA and no identified risk
were more likely to be susceptible to other antibiotics when compared to CA-MRSA
with identified risk and nosocomial isolates. [1]
Another pediatric chart review study was performed by Gorak, Yamada, and
Brown. This study was conducted from 1992-1996 using patients hospitalized with
CA-MRSA infections in Honolulu. [3] The purpose was to assess the patients risk
factors. [3] All the medical records of patients admitted with CA-MRSA were ana-
lyzed. [3] Patients were excluded if they had a previous hospitalization within the
past six months, transferred from other hospitals, or were residents of nursing homes
or other long-term care facilities. [3] The records were reviewed for residency status,
travel history, admitting service, history of alcohol, tobacco, and intravenous drug
use, family member or close contact with pyoderma, previous antimicrobial therapy,
surgical intervention, site of culture, antimicrobial susceptibilities, and underlying
medical conditions. Of clinically infected patients, 93 % had skin and soft tissue
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infections. [3] Community acquired isolates were susceptible to a greater number of
antibiotics. [3] This study was unique because the patient population in these hospi-
tals were primarily young and healthy military men. [3]
Fergie and Pucell conducted a retrospective study to report the frequency of CA-
MRSA isolates, describe the spectrum of disease of children infected with CA-MRSA
and compare the antibiotic susceptibility patterns of Community-Acquired and noso-
comial MRSA infections. [20] All cases of Staphylococcus aureus were identified from
October to December 2000. [20] The medical records were reviewed for all children
with CA-MRSA and the following information was recorded from the charts: diag-
nosis, site of culture, antibiotic susceptibility, and presence of any known risk fac-
tors. [20] These risk factors were underlying chronic disease, residence in a long-term
care facility, day care attendance, household contact with identified risk factors, re-
cent hospitalization or surgery, presence of an indwelling catheter, intravenous drug
use, and previous antibiotic use. [20] The prevalence of CA-MRSA was 47% with 88%
of these cases having no identified risk. Soft tissue infections accounted for 91% of
these cases. [20] CA-MRSA accounted for 12% of the MRSA isolated from 1990-1996
and 59% from 1997-2000 peaking at 80% in 2000. [20] The annual rate of MRSA
isolation increased from 2.9% of all Staphylococcus aureus isolates in 1990 to 19.0%
in 2000. [20] CA-MRSA isolates from children without identified risk were more likely
to be susceptible to trimethoprim-sulphamethoxazole and clindomycin. [20] Nosoco-
mial isolates were more susceptible to tetracycline. [20] This study has demonstrated
a dramatic increase in CA-MRSA in children with no known predisposing risk fac-
tors. [20]
A retrospective cohort study was conducted by Campbell et al to describe the
relative contribution of risk factors for both Community-Acquired and nosocomial
MRSA infections. [21] The participants were all children with MRSA infections, at
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a tertiary care children’s hospital between October 1999 and September 2001. [21]
Medical records were used to collect data on demographics, date and site of culture,
diagnosis, initial and final antibiotic and surgical therapy, and previous medical, mi-
crobiological, surgical, and device history. [21] The sample size was 62. [21] Patients
with CA-MRSA tended to be older with a median age of 5.5 years versus 1.5 years. [21]
Significant risk factors for CA-MRSA were previous surgery and antibiotics at pre-
sentation. [21] Exposure to endotracheal tubes, central vascular catheters, and chest
tubes were less common in CA-MRSA patients and resistance patterns were simi-
lar between Community-Acquired and nosocomial isolates. [21] Only 8% of patients
with CA-MRSA had no health-care risk. [21] These researchers concluded that the
majority of Community-Acquired cases were in reality nosocomial cases due to sim-
ilar resistance patterns and the presence of risk factors including contact with the
health-care environment. [21] This risk factor alone could have led to colonization
which later progressed to infection. [21] This obscured the likelihood of nosocomial
transmission and delayed the investigation of poor adherence with infection control
practices. [21]
There have been two studies conducted with children at daycare centers following
the diagnosis of a child with Methicillin-Resistant Staphylococcus aureus. Shahin et al
conducted a study of the prevalence of MRSA and Methicillin-Sensitive Staphylococcus
aureus colonization in a child care center in Toronto. [31] The index case of CA-MRSA
was a two and a half year old child. [31] Consenting parents completed a questionnaire
and permitted screening of their children from throat, nose, and perianal sites and
nasal and perianal swabs were obtained from the child center staff. [31] There was a
response rate of 81.8% for children and 100% for staff. [31] Positive Staphylococcus
aureus cultures were recovered from 24.4 % of children. [31] Only one classmate and
the sibling of the index case had positive Methicillin-Resistant Staphylococcus aureus
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cultures. [31] The classmate had a diagnosis of dermatitis that preceded the index case
for this by three months which raises the possibility that the index case in this study
may actually be a secondary case. [31] All three children’s isolates had similar pulse
field gel electrophoresis profiles. [31] No risk factors were found to be significantly
associated with positive Staphylococcus aureus isolates. [31]
A second study was conducted by Adcock et al of the prevalence of MRSA col-
onization at two child care centers. [32] These two centers had a child hospitalized
for MRSA infections. [32] A culture of the anterior nares and axilla was taken from
each child and child care provider. [32] Parents and child care providers completed a
questionnaire about factors associated with MRSA infections. [32] At day care center
one, the colonization rate of MRSA was 24% and day care center two had a rate of
3%. [32] At day care center one two strains of MRSA were isolated and were asso-
ciated with two different classrooms. [32] At day center two, one strain was isolated
from the index case and a colonized child. [32] Of all children, 60% had contact with
a health-care facility or had a household member who had contact with a health-
care facility within two years prior to the study. [32] However, this result was not
significant because the P-value is too large. [32]
Two community colonization prevalence studies were preformed. The first was
conducted by Hussain, Boyle-Vavia, and Duam. The purpose of their study was to
ascertain whether healthy children attending an outpatient clinic were colonized with
MRSA . [19] The study was performed at a primary outpatient facility at University
of Chicago from January to August 1999. [19] Children sixteen years and younger at-
tending the clinic for well child visits were eligible for the study. [19] Those eligible had
specimens obtained from the nares and perineum. Of the 500 children tested, 24.4%
were colonized with Staphylococcus aureus and of those colonized, three isolates had
MRSA. [19] Two of the MRSA colonized children had a predisposing risk factor. [19]
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The generalizablity of the study is in question due to the fact that this clinic was in
the inner city in which the majority of patients were African American. [19]
The second community colonization study was performed by Nakamura et al.
The study was conducted to ascertain the prevalence of nasal carriage of MRSA in
Nashville, TN. [22] Children receiving well child visits at either a university pediatric
clinic or private pediatric office were eligible for enrollment regardless of chronic med-
ical conditions. [22] Nasal swabs were collected and a questionnaire was administered
to collect demographic data and risk factors. [22] Of the 500 enrolled patients, 29%
were colonized with Staphylococcus aureus and of those colonized patients, four were
colonized with MRSA. [22] None of the patients had risk factors, but all had house-
hold contacts with risk factors. [22] The risk factors of the household contacts that
were analyzed are chronic illness, hospitalization, employment in the healthcare in
a hospital or long term care facility, and community worn device. [22] Of these risk
factors, only employment in a hospital or long term care facility was significant. [22]
The MRSA isolates were susceptible to many antibiotics except erythromycin. [22]
Sattler, Mason, and Kaplan conducted a prospective observational study to com-
pare the presence of risk factors for methicillin resistance between CA-MRSA and
Community-Acquired Methicillin-Sensitive Staphylococcus aureus patients and house-
hold contacts, as well as the demographic and clinical characteristics between pa-
tients. [2] The study was conducted in Houston, Texas at Texas Children’s Hospital
from February 2, 2000 to November 14, 2000 excluding two one month periods in
May and September. [2] Inpatients and outpatients were eligible if the isolate was
community-acquired. [2] Patients were excluded if they had any underlying illness pre-
disposing them to frequent hospitalizations, hospitalization in the prior six months,
infants less than six months old who had been hospitalized during the neonatal pe-
riod greater than 72 hours, or outpatient surgery within the past six months. [2] Risk
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factors were assessed by interview and included antibiotic exposure, prior hospital-
izations, health-care visits, daycare attendance, health-care worker or nursing home
resident contact, and presence of underlying illness. [2] None of these risk factors
were found to be statistically significant. [2] Of the 144 enrolled, 44% were MRSA.
This organism was more frequently recovered from African Americans. [2] Methicillin-
Sensitive Staphylococcus aureus infections tended to be deep-seated when compared
to MRSA infections. [2] Recall bias of the presence of risk factors was decreased by
excluding patients if the investigator or patient’s guardian were aware of the antibiotic
susceptibility test results. [2]
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CHAPTER 4
METHODS
4.1 Study Design
This is a cross-sectional study of children 18 years or younger, who have a positive
Staphylococcus aureus culture as an outpatient or within 72 hours of becoming an
inpatient at All Children’s Hospital in St. Petersburg, Florida.
4.2 Institutional Review Board
This study received approval by the Institutional Review Board at All Children’s
Hospital (ACH #03-0747) on July 29, 2003. The study was also submitted to the
Institutional Review Board at Univerisity of South Florida , who deferred approval
of the study to the All Children’s Hospital Institutional Review Board. This study
was performed under the supervision of Roger Sanderson, the regional epidemiologist
for the Florida Department of Health. The principle investigator became an offi-
cial Department of Health Volunteer and was therefore given access to the medical
records. Patient confidentiality was assured by not removing the medical charts from
All Children’s Hospital grounds. Limited private health information was entered into
the database in order to ensure that the patients in the study population could not
be identified. A unique number was assigned by the database, and therefore, subjects
names and dates of birth were not abstracted from the charts. The only unique pa-
tient information that was abstracted from the medical charts was date of admission
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to the hospital, date of culture, and date of discharge from the hospital. Courses
of Health Insurance Portability and Accountability Act (HIPAA) guidelines and the
National Institute of Health Protection of Human Subjects were also taken by the
Principle Investigator.
4.3 Study Population
All patients admitted to All Children’s Hospital or seen as an outpatient in the
Emergency room at All Children’s Hospital St. Petersburg, Florida from January 1,
2002 to August 20th, 2003 were eligible for entry into the study. Records after August
20 were unavailable because the hospital infection control department had not yet
updated their files. In order to be enrolled into the study, the patients also must have
a positive culture for Staphylococcus aureus. Positive cultures from inpatients had to
be collected within 72 hours of being admitted to the hospital. Patients who were
admitted multiple times during the study period where only enrolled once using the
first admission with a positive culture result.
4.4 Inclusion Criteria
Patients were enrolled if they were under 18 years of age at admission and had a
positive Staphylococcus aureus culture within the first 72 hours of admission or had
a positive culture as an outpatient.
4.5 Exclusion Criteria
Subjects were excluded if their charts were unavailable for review. Charts were un-
available if the patient was currently hospitalized or if the patients visited an outpa-
tient clinic associated with the hospital.
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4.6 Sources of Data
All of the data, for this study, was obtained from a chart review at All Children’s
Hospital in St. Petersburg, Florida. The hospital provided a computer generated list
of all positive Staphylococcus aureus cultures for the study period of January 1, 2002
to August 20, 2003. The medical charts of all patients who met the study criteria
were reviewed.
4.7 Data Collection
Data was collected by performing a chart review of 672 patients. All reviews were
performed at All Children’s Hospital. A standardized form was made using Microsoft
Access and was utilized on all charts. The principle investigator performed all chart
reviews.
Patient confidentiality was maintained by ensuring that no private health infor-
mation was utilized in the study. No names or date of births were abstracted from
the medical charts in order to assure patient confidentiality. All of the data collec-
tion took place at All Children’s Hospital and the charts were promptly returned to
medical records after data entry was completed.
Some of the information needed to assess the patients risk for getting a Staphy-
lococcus aureus infection was missing. The missing information was marked as ”not
noted” for the particular question in the database. Seventeen subjects out of 672 had
some missing data from their charts. The percentage of charts reviewed with missing
data was 2.5%.
4.8 Definitions and Classification of Variables
The following variables were collected for this study and are defined below.
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Age: The age of a patient was determined as the subjects age at date of culture.
Race/Ethnicity: This variable was collected as indicated on the subjects medical
chart. White, Black, Asian, American Indian, or other were defined as races. Eth-
nicity was defined as either Hispanic or non-Hispanic. Note: All Children’s Hospital
defined Hispanic as a race in medical records.
Outcome/Transfer: This variable identified where the patient was going after
being discharged from the hospital. The possible categories were home, long-term
care facility, rehabilitation hospital, other hospital, or dead.
Previous Antibiotic Use: Previous antibiotic use was defined as any use of
antibiotics within the previous 12 months as noted on the medical chart.
Previous Surgery: The variable is noted as a patient having any surgery within
the past 12 months prior to the date of culture.
Outpatient Surgery: Outpatient surgery within the previous 12 months prior
to the culture.
Patient Receiving Home Health Care: The variable was defined as a patient
receiving home health care within the previous 12 months prior to the date of culture.
Previous MRSA Infection: This variable was identified as a patient having a
previous infection with Methicillin-Resistant Staphylococcus aureus as noted on the
medical chart.
Resident of a Facility within 12 Months of Admission: A patient that lived
in a long-term care facility or rehabilitation hospital 12 months prior to the culture
date.
Community Worn Device at the Time of Admission: These devices were
defined as dialysis-related, urinary/ foley catheter, PIC line, Central line, and other
lines (PEG, J tube, shunts) in place at the time of admission. Endotracheal tubes
were also included in the ”other” category.
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Cardiovascular Disease: A patient with any history of arteriovenous malfor-
mations, congenital heart defects, pulmonary atresia, or Scimitar syndrome as noted
on the medical chart.
Liver Disease: A patient with any history of acute hepatitis, or any congenital
abnormalities of the liver as noted on the medical chart.
Pulmonary Disease: A history of asthma, cystic fibrosis, or broncho-pulmonary
dysplasia as noted on the patient’s medical chart .
Neurologic Disease: A patient with a history of any encephaly, skull or spinal
deformities, cerebral palsy, Down’s syndrome, or demyelinating disease as noted on
the medical chart.
Immuno Therapy: A patient who was undergoing treatment with corticos-
teroids or chemotherapy/radiation therapy within the previous 12 months as noted
on the medical chart.
Chronic Dermatological Condition: A patient with any history of eczema,
psoriasis, dermatitis, or decubitus ulcers as noted on the medical chart.
4.9 Statistical Analysis
Data for the study was analyzed with the Epi Info software package from the Centers
of Disease Control and Statistical Analysis Software (SAS). The data was analyzed
both descriptively and analytically. The frequencies for the demographic characteris-
tics as well as the risk factors were obtained. Univariate Analysis was conducted for
each risk factor and a crude odds ratio and a 95% confidence interval were obtained
from Epi Info. Race specific analysis was then conducted which suggested that effect
modification may be present. Analysis was conducted utilizing the logistic regression
function, proc logistic in SAS to assess if race was an effect modifier for any of the
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risk factors. This analysis confirmed that race was an effect modifier for the variable
previous antibiotic use. The logistic regression function was also used to adjust the
risk factors for the presence of confounding.
A variable was created to reflect multiple exposures to healthcare to determine
if risk increased as the numbers of potential exposures increased. The total number
of risk factors for each subject was tabulated and analysis was preformed looking for
a dose response relationship. The subjects were broken into four categories: those
with no risk factors, 1 risk factor, 2 risk factors, and greater than 2 risk factors. Each
group was compared with the the no risk factor group. The same procedure was
utilized to adjust for confounding and assess if effect modification was present as was
outlined above.
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CHAPTER 5
RESULTS
5.1 Demographic Characteristics
Demographic characteristics of the study participants are indicated in Table 1. In
this study a total of 672 charts were reviewed and there were 126 cases of MRSA
infection. The results are shown as the total study population and then broken into
those with MSSA and MRSA.
Age: Subjects were enrolled in the study if they were 18 years old or younger
at the time of admission. For analysis, age was broken into 5 categories: less than
1 year old, 1-4 years old, 5-9 years old, 10-14 years old, and 15-18 years old. The
1-4 year old group was the largest in the study and the 15-18 year old group was
the smallest. These age categories were chosen in order to maintain consistency with
CDC and Florida Department of Health age reporting standards. Table 1 shows the
distribution of age as a whole group as well as a comparison of the MRSA and MSSA
groups.
Race: All races and ethnicities were eligible for the study. The majority of
subjects were non-Hispanic whites, followed by black, then Hispanic whites. Table 1
shows the break down of the study population by race. When compared with the total
population by race in Pinellas county, 7.7% of of the county population is black and
2.4% are Hispanic in the total population as compared with the study population
where 15.2% are black and 9.1% are Hispanic. The race breakdown in the study
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Total MRSA MSSA
Number % Number % Number %
Age
less than 1 yr 84 12.5 12 14.3 72 85.7
1 - 4 yr 243 36.2 58 23.9 185 76.1
5 - 9 yr 199 29.6 26 13.1 173 86.9
10 - 14 yr 104 15.5 20 19.2 84 80.8
15 - 18 yr 42 6.2 10 23.8 32 76.2
Race
White 482 71.7 74 15.4 408 84.6
Black 102 15.2 36 35.3 66 64.7
Asian 11 1.6 1 9.1 10 90.1
Hispanic 61 9.1 10 16.4 51 83.6
Other 16 2.4 5 31.3 11 68.7
Gender
Male 424 63.1 71 16.7 353 83.3
Female 248 36.9 55 22.2 193 77.8
Risk Factors
Community Worn Device 81 12.1 28 34.6 53 65.4
Previous Antibiotic Use 210 31.3 53 25.2 157 74.8
Home Health Care 23 3.4 12 52.2 11 47.8
Previous Hospitalization 190 28.3 56 29.5 134 70.5
Previous MRSA Infection 36 5.4 16 44.4 20 55.5
Previous Surgery 141 26.9 41 29.1 100 70.9
Previous Outpatient Procedure 56 8.3 14 25.0 42 75.0
Immunotherapy 17 2.5 2 11.8 15 88.2
Residence in a Facility 17 2.5 6 35.3 11 64.7
Medical Conditions
Cancer 13 1.9 2 15.4 11 84.6
Cardiovascular Disease 22 3.3 8 36.4 14 63.6
Chronic Dermatological Conditions 45 6.7 10 22.2 35 77.8
Diabetes 6 0.9 1 16.7 5 83.3
Liver Disease 9 1.3 4 44.4 5 55.6
Neurologic Disease 72 10.7 19 26.4 53 73.6
Pulmonary Disease 181 26.9 37 20.4 144 79.6
Table 1. Characteristics of study participants age 18 or younger seen at All Children’s
Hospital 1/1/02 - 8/20/03 in total and by methicillin status.
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Odds Ratio 95% Confidence Interval
Risk factors
Community Worn Device 2.65 1.60, 4.41
Previous Antibiotic Use 1.79 1.40, 2.20
Home Health Care 5.12 4.28, 5.96
Previous Hospitalization 2.46 2.06, 2.86
Previous MRSA infection 3.83 1.92, 7.62
Previous Surgery 2.15 1.72, 2.58
Black 2.98 2.51, 3.45
Female 1.42 0.95, 2.10
Medical Conditions
Cardiovascular Disease 2.58 1.74, 3.47
Chronic Dermatological Conditions 1.26 0.53, 1.99
Neurologic Disease 1.65 1.09, 2.22
Pulmonary Disease 1.16 0.32, 2.00
Total Risk Factors
0 Risk Factors Present 1.00 -
1 Risk Factor Present 1.30 0.79, 1.81
2 Risk Factors Present 2.45 1.83, 3.07
greater than 2 Risk Factors Present 5.82 5.26, 6.38
Table 2. Odds Ratios and Confidence Intervals for Risk Factors for MRSA infections
in children age 0 - 18 years at All Children’s Hospital 1/1/02 - 8/20/03.
population is comparable with Florida and United States, with 14.6% black in Florida
and 12.3% black in the United States. Hispanics make up 16.8% of the population in
Florida and 12.5% in the United States.
Gender: The breakdown of the study population by gender is shown in Table 1.
In this study 36.9% of the subjects were female. This is significantly lower than in
Pinellas county (53.3%), Florida (51.2%), and the US (50.9%).
5.2 Risk Factors for Methicillin-Resistant Staphylococcus aureus
Data for eight risk factors were collected from each subjects medical chart. The
risk factors were community worn device, previous antibiotic use, home health care,
previous hospitalization, previous surgery, previous MRSA infection, immunotherapy,
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and residence in a facility. Table 1 shows the breakdown on the distribution of the
risk factors by total population and a breakdown by methicillin resistance status.
The variable residence in a facility and immunotherapy were not analyzed due to the
small number of subjects with these risk factors. Table 2 shows the crude odds ratios
and the 95% confidence intervals for each of the risk factors. Gender was found not
to be associated with MRSA infections (OR=1.42, CI= 0.95, 2.10)(Table 2). Blacks
were found to be at a greater risk to be diagnosed with an MRSA infection than
whites (OR= 2.98, CI= 2.51, 3.45). (Table 2) Community worn device (OR= 2.65,
CI= 1.60, 4.41), previous antibiotic use (OR= 1.79, CI= 1.40, 2.20), home health
care (OR= 5.12, CI= 4.28, 5.96), previous hospitalization (OR= 2.46, CI= 2.06,
2.86), previous MRSA infection (OR= 3.83, CI= 1.92, 7.62), and previous surgery
(OR= 2.15, CI= 1.72, 2.58) were all found to be statistically significant risk factors
for MRSA infection.
5.3 Medical Conditions
It was hypothesized that certain medical conditions may predispose subjects to an
MRSA infection. These medical conditions were cancer, cardiovascular disease, chronic
dermatological conditions, diabetes, liver disease, neurological disease, and pulmonary
disease. Table 1 shows the breakdown of medical conditions in the total study popula-
tion and by methicillin status. Cancer, liver disease, and diabetes were not analyzed
due to the small number of subjects that demonstrated these disorders. Table 2
demonstrated the crude odds ratios and 95% confidence intervals for each of the
medical conditions that were analyzed. Of these, only cardiovascular disease (OR=
2.58, CI= 1.74, 3.47) and neurologic diseases (OR= 1.65, CI= 1.09, 2.22) were shown
to be associated with MRSA infection (Table 2). The reason that these medical con-
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ditions are associated with MRSA infection is that they often require more frequent
contact with healthcare providers in order to monitor and treat their illness.
5.4 Total Risk Factors
As many of the risk factors of interest reflect opportunities to acquire hospital based
infections, a variable was created to reflect multiple exposures to care to determine
if risk increased as the numbers of potential exposures increased. The total number
of risk factors for each subject was tabulated and analysis was preformed looking for
a dose response relationship. The subjects were broken into four categories: those
with no risk factors, 1 risk factor, 2 risk factors, and greater than 2 risk factors.
Each group was compared with the the no risk factor group. The more risk factors
that a subject possessed, the greater their risk for MRSA infection (Table 2 ). There
were only 35 out of 126 MRSA patients that had no risk factors for MRSA infection
documented in their chart. This is a prevalence of 28%. This finding demonstrates
that the majority of MRSA infections in this study were associated with some kind of
previous exposure to the healthcare setting and were not truly community acquired
infections.
5.5 Effect Modification
Testing for effect modification was performed in SAS because univariate analysis sug-
gested that race may be an effect modifier for the risk factors. Effect modification was
tested between race and all risk factors. Race was an effect modifier only for the risk
factor of previous antibiotic use (pvalue =.02). This finding suggests that race plays
a role in a subjects access to antibiotics. This finding may be explained by the fact
that whites traditionally have more access to healthcare than blacks. This would give
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Total MRSA MSSA
Number % Number % Number %
Age
less than 1 yr 17 16.7 5 29.4 12 70.6
1 - 4 yr 34 33.3 14 41.2 20 58.8
5 - 9 yr 20 19.6 7 35.0 13 65.0
10 - 14 yr 25 24.5 8 32.0 17 68.0
15 - 18 yr 6 5.9 2 33.3 4 66.7
Gender
Female 39 38.2 19 48.7 20 51.3
Risk Factors
Community Worn Device 14 13.7 8 57.1 6 42.9
Previous Antibiotic Use 28 27.5 18 64.3 10 35.7
Home Health Care 5 4.9 3 60.0 2 40.0
Previous Hospitalization 35 34.3 16 45.7 19 54.3
Previous MRSA Infection 4 3.9 2 50.0 2 50.0
Previous Surgery 20 19.6 11 55.0 9 45.0
Total Risk Factors
0 Risk Factors 49 48.0 12 24.5 37 75.5
1 Risk Factors 28 27.5 8 28.6 20 30.3
2 Risk Factors 9 8.8 6 16.7 3 71.4
greater than 2 Risk Factors 16 15.7 10 62.5 6 37.5
Table 3. Characteristics of black study participants age 18 or younger seen at All
Children’s Hospital 1/1/02 - 8/20/03 in total and by methicillin status.
white children more exposure to healthcare as a total population. It may be hypoth-
esized that only the sickest of black children are exposed to healthcare and as a result
more susceptible to MRSA infection Table 3 and Table 4 illustrates the breakdown
of each of the risk factors within their respective race as a total population and by
methicillin status. As a result of effect modification of race being present, subjects
were categorized according to race and then odds ratios and confidence intervals were
computed. This analysis was performed on blacks and whites. Hispanics were in-
cluded with the white population. All other races and ethnicities were present in too
small numbers to permit analysis. The risk factors that were significant in whites were
home health care (OR= 6.12, CI= 5.16, 7.08), community worn device (OR= 2.28,
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Total MRSA MSSA
Number % Number % Number %
Age
less than 1 yr 60 11.1 5 8.3 55 91.7
1 - 4 yr 199 36.7 42 21.1 157 78.9
5 - 9 yr 172 31.7 18 10.4 154 89.6
10 - 14 yr 78 14.4 12 15.4 66 84.6
15 - 18 yr 34 6.3 7 20.6 27 79.4
Gender
Female 198 36.5 34 17.2 164 82.8
Risk Factors
Community Worn Device 63 11.6 17 27.0 46 73.0
Previous Antibiotic Use 173 31.9 31 17.9 142 82.1
Home Health Care 18 3.3 9 50.0 9 50.0
Previous Hospitalization 144 26.5 36 25.0 108 75.0
Previous MRSA Infection 29 5.3 11 37.9 18 62.1
Previous Surgery 119 21.9 28 23.5 91 76.5
Total Risk Factors
0 Risk Factors 221 40.7 22 10.0 199 90.0
1 Risk Factors 193 35.5 27 14.1 166 85.9
2 Risk Factors 65 12.0 11 16.9 54 83.1
greater than 2 Risk Factors 63 11.6 24 38.1 39 61.9
Table 4. Characteristics of white study participants age 18 or younger seen at All
Children’s Hospital 1/1/02 - 8/20/03 in total and by methicillin status.
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White Black
Odds Ratio CI Odds Ratio CI
Female 1.22 0.74, 1.70 2.57 1.73, 3.41
Risk Factors
Home Health Care 6.12 5.16, 7.08 2.95 1.11, 4.79
Community Worn Device 2.28 1.67, 2.89 2.85 1.71, 4.01
Previous Hospitalization 2.43 1.95, 2.91 1.98 1.13, 2.83
Previous MRSA Infection 3.69 2.90, 4.48 1.88 -0.12, 3.89
Previous Surgery 2.02 1.51, 2.53 2.79 1.79, 3.79
Previous Antibiotic Use 1.31 0.81, 1.79 5.60 4.66, 6.54
Total Risk Factors
0 1.00 1.00
1 1.23 0.63, 1.83 1.23 0.18, 2.28
2 1.84 1.06, 2.62 6.17 4.03, 7.70
greater than 2 5.57 4.90, 6.24 5.14 3.94, 6.34
Table 5. Odds Ratios and 95% Confidence Intervals for Subgroup Analysis of Black
and White of Children ages 0 - 18 years from All Children’s Hospital 1/1/02 - 8/20/03
CI= 1.67, 2.89), previous hospitalization (OR= 2.43, CI= 1.95, 2.91), previous MRSA
infection (OR= 3.69, CI= 2.90, 4.48), and previous surgery (OR= 2.02, CI= 1.51,
2.53) (Table 5). All of these risk factors increased the subjects contact with health-
care and therefore increased the likelihood of acquiring MRSA infection. In blacks,
pediatric females were more likely to have MRSA (OR= 2.57, CI= 1.73, 3.41). This
finding may be due to the small sample size of black children in the study. Of the
analyzed risk factors, home health care (OR= 2.95, CI= 1.11, 4.79), community worn
device (OR= 2.85, CI= 1.71, 4.01), previous hospitalization (OR= 1.98, CI= 1.13,
2.83), previous surgery (OR= 2.79, CI= 1.79, 3.79), and previous antibiotic (OR=
5.60, CI= 4.66, 6.54) use were all significant risk factors in blacks (Table 5). With
these risk factors contact with the healthcare environment and healthcare workers is
increased and therefore increases the possibility of acquiring an MRSA infection.
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White Black
Odds Ratio 95% CI Odds Ratio 95% CI
Age 0.98 0.93, 1.03 1.00 0.92, 1.10
Female 1.19 0.72, 1.95 1.88 0.72, 4.90
Previous Antibiotic Use 1.10 0.65, 1.86 5.13 1.75, 15.08
Community Worn Device 0.98 0.46, 2.09 0.93 0.18, 4.88
Home Health Care 4.37 1.55, 12.32 1.96 0.19, 20.84
Previous MRSA Infection 2.86 1.16, 7.05 0.65 0.06, 6.98
Previous Hospitalization 2.00 1.14, 3.50 0.77 0.25, 2.41
Previous Surgery 1.25 0.68, 2.29 1.94 0.50, 9.56
1 Total Risk Factor 1.47 0.80, 2.67 1.30 0.45, 3.76
2 Total Risk Factors 1.85 0.84, 4.05 5.50 1.16, 26.16
greater than 2 Total Risk Factors 5.36 2.74, 10.49 4.19 1.20, 14.61
Table 6. Adjustment of Confounding for Black and White of Children ages 0 - 18
years from All Children’s Hospital 1/1/02 - 8/20/03
5.6 Confounding
Logistic regression was used to adjust for confounding. Adjustment of confounding
was performed for each race due to the presence of effect modification. After the
adjustment for confounding in whites, only home health care (OR=4.37 CI= 1.55,
12.32), previous MRSA infection (OR= 2.86 CI= 1.16, 7.05), and previous hospital-
ization (OR= 2.00 CI= 1.14, 3.50) remained statistically significant (Table 6). In
blacks, after adjustment of confounding, only previous antibiotic use (OR= 5.13 CI=
1.75, 15.08) remained significant. Adjustment for confounding was also preformed on
the total risk factors model. A dose response relationship was present with increasing
risk factors present (Table 6).
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CHAPTER 6
DISCUSSION
6.1 Findings
The results of this study indicate several factors in the population of pediatric patients
that lead to MRSA infection. In regards to demographic characteristics, black children
are 2.98 times more likely to have an MRSA infection than white children. Gender
and age were not risk factors for the development of the infection. The risk factors
that were significant in whites were home health care (OR= 6.12, CI= 5.16, 7.08),
community worn device (OR= 2.28, CI= 1.67, 2.89), previous hospitalization (OR=
2.43, CI= 1.95, 2.91), previous MRSA infection (OR= 3.69, CI= 2.90, 4.48), and
previous surgery (OR= 2.02, CI= 1.51, 2.53). In blacks, females were more likely
to have MRSA (OR= 2.57, CI= 1.73, 3.41). This finding may be due to the small
sample size of black children in the study. Of the analyzed risk factors, home health
care (OR= 2.95, CI= 1.11, 4.79), community worn device (OR= 2.85, CI= 1.71,
4.01), previous hospitalization (OR= 1.98, CI= 1.13, 2.83), previous surgery (OR=
2.79, CI= 1.79, 3.79), and previous antibiotic (OR= 5.60, CI= 4.66, 6.54) use were
all significant risk factors in blacks. Effect modification was tested between race
and all risk factors. Race was an effect modifier only for the risk factor of previous
antibiotic use (pvalue =.02). Race may be an affect modifier due to the fact that
blacks may be more likely to utilize emergency rooms and urgent care centers to have
their child treated for an illness. Whites are traditionally known to have better and
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more assess to healthcare and may therefore be more likely to take their child to a
doctors office than take their child to the emergency room to have an illness treated.
Adjustment of confounding was performed for each race due to the presence of effect
modification. After the adjustment for confounding in whites, only home health
care (OR=4.37 CI= 1.55, 12.32), previous MRSA infection (OR= 2.86 CI= 1.16,
7.05), and previous hospitalization (OR= 2.00 CI= 1.14, 3.50) remained statistically
significant. In blacks, after adjustment of confounding, only previous antibiotic use
(OR= 5.13 CI= 1.75, 15.08) remained significant. Adjustment for confounding was
also preformed on the total risk factors model. A dose response relationship was
present with increasing risk factors present.
As compared to this study, the results of other MRSA studies on adults had
some discrepancies and some similarities. Abudu et al conducted a study comparing
MRSA and MSSA with regard to previous hospitalization, recent antibiotic use, and
any contact with a healthcare facility. [27] None of those risk factors were found
to be statistically significant. [27] This is contradictory to the current study which
demonstrated many risk factors that were significant to the development of MRSA
infections. The inconsistency may be explained by a poor response rate of 58% which
suggests a strong likelihood of the presence of selection bias. [27] A study conducted by
Morin and Hadler found an increase of the incidence of MRSA in males and blacks. [29]
Gender was not found to be a risk factor for MRSA infection in the current study. The
discrepancy with regard to gender may be explained by the type of study that was
conducted which only included patients with bacteremia and excluded all patients
with other types infections. [29] However, both the current study and the Morin
and Hadler study found race to be a risk factor for MRSA infection. [29] A study
conducted by Johnson et al reported an increase risk with previous hospitalization
and residence in a facility. [17] These results are consistant with this study except
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for the fact that there were not enough patients who resided in a facility to permit
statistical analysis. Grundmann et al reported an increase risk of MRSA infection
with previous hospitalization and patients with diabetes. [28] There were not enough
patients with diabetes in this study to permit statistical analysis but it was found
that previous hospitalization was statistically significant.
As compared to the current study, the results of other studies of MRSA on children
showed some similarities as well as some discrepancies. The study by Sattler et al
found that blacks were more likely to have MRSA than whites or Hispanics, which
is consistent with the results of this study. [2] The study by Sattler et al did also
report that there was no significant differences in the exposure to risk factors between
the MRSA and the MSSA group. [2] This finding is inconsistent with the current
study which found significant risk associated with MRSA for those with many of
the risk factors as well as race. This discrepancy may be to due the small sample
size of 144 subjects of the Sattler et al study. [2] Herold et al found an association
between age and MRSA, 89% of the MRSA isolates were from children ages three to
36 months which was hypothesized to be a result of the childrens’ exposure to a day
care setting. [1] This is not consistent to the results in this study in which age was not
found to be a risk factor for MRSA. This discrepancy may be due to the small sample
size of 88 subjects as well as the specialization of the hospital where the study was
conducted. [1] The study was conducted at University of Chicago Children’s Hospital
which is a tertiary care pediatric hospital in the inner city of Chicago. [1] Herold
et al also reported an increase of MRSA infection in blacks which is consistent with
the findings of this study. [1] The study conducted by Campbell et al found that
males were twice as likely to have CA-MRSA. [21] Campbell et al also found the CA-
MRSA patients were more likely to be older and to have received antibiotics prior
to admission. [21] Age and gender were not found to be risk factors in the current
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study but previous antibiotic use and community worn device were found to be a risk
factor. The discrepancy between the studies with regard to gender and age may be
explained by the small sample size of 62 subjects by the Campbell et al study. [21]
6.2 Strengths & Weaknesses of the Study
The strengths of this study are the large sample size which increases the power of the
study. The 20 month length of the study period is also a strength. The cross-sectional
design used in this study allowed for the evaluation of multiple risk factors. A cross
sectional study enables the resulting data from the study to be utilized to calculate
prevalence estimates of exposure and disease.
A weakness of the study is that it was only performed at one hospital. The
results must be generalized with caution. The population may not closely mirror
the pediatric population of Pinellas county or the state of Florida due to the high
amount of transfers to All Children’s Hospital from many of the adjacent counties.
This may result in the hospital having an overall sicker population than other pediatric
populations seen in other hospitals. The main weakness of the cross sectional study
design is that temporal sequence between exposure and disease can be difficult to
establish. This was not an issue in this study because the risk factors that were
collected were specifically defined as having taken place in the previous 12 months
prior to the positive culture. There is also a question of accuracy of the medical
charts to reflect the presence of the subjects risk factors. Several patients were not
listed as having previous antibiotic use when their history and diagnosis would suggest
otherwise. This may have lead to misclassification of those patients with regards to
exposure status.
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There are two main types of bias that may have played a role in this study. The
first is selection bias which occurs when those enrolled in the study cause an associ-
ation to be present or absent when in reality the opposite is true. This could have
occurred as a result of the charts that were unavailable for review. The charts that
were unavailable were those of patients currently hospitalized and those of patients
only seen in the outpatient clinics associated with All Children’s Hospital. Out of 827
charts that were requested 155 of them were unavailable for review. The most com-
mon reason was that the child was seen in the outpatient clinic. This is approximately
an 82% response rate. This could have introduced some selection bias into the study.
The other type of bias that may have played a role in this study was information
bias which occurs when the information about the subjects enrolled in the study is
incorrect or missing. This may cause a subject to be classified incorrectly in regards
to either exposure or outcome causing misclassification bias. In this study there may
have been inadequate documentation of the presence of risk factors for MRSA. Infor-
mation bias can also occur when information on other possible confounding factors
is not available because of the limited amount of data collected in the chart. This
could be the case with some of the risk factors that were listed in other studies. For
example, child’s attendance in daycare and family member’s exposure to healthcare
are risk factors that could have created bias. Information bias can also be caused
by a misclassification according to disease status. This could result in a patient with
MRSA not being identified as such. Information bias could happen if there was an
instrument malfunction or if the medical technologist entering the results made a
typographical error.
Some other types of bias that may be present are recall bias and interviewer bias.
Recall bias occurs when there is inaccurate recall of past exposure. This could be
a common problem when a parent is more worried about the immediate welfare of
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their child than the questions that are being asked by the doctor or nurse filling out
the paperwork. It is possible that the amount of recall bias could differ by whether
the child had MRSA or MSSA. This may be a result of the child with the resistant
infection having more contact with healthcare and therefore the parent would be more
likely to recall the presence of risk factors in their child. Interviewer bias is a type of
information bias in which the means for obtaining the information about the study
subject leads to incorrect assessment of exposure or disease status. This type of bias
could have occurred in this study as a result of each subject not having the same
nurse or doctor interview them. Each healthcare professional has a different way of
completing the necessary forms. This alone is enough to introduce interviewer bias.
6.3 Future Directions
Many of the previous studies mentioned that the susceptibility patterns were similar
in CA-MRSA and nosocomial MRSA isolates. [30, 17, 33, 27, 18, 28, 22, 19, 34, 2, 1]
This suggests that the infections were really the result of the same strain of MRSA.
MRSA that is nosocomially acquired typically is resistant to multiple antibiotics
where CA-MRSA is only typically resistant to penicillin and methicillin. [30, 17, 33,
27, 18, 28, 22, 19, 34, 2, 1] Therefore it is important to assess the patient previ-
ous healthcare exposure in order to distinguish between CA-MRSA and nosocomial
MRSA. Assessing this exposure has been made more difficult with the increase in
outpatient procedures and the decrease in overall hospital stays for many surgeries.
This decrease or absent hospital stay may lead to poor patient recall as well as an
increase in the patients exposure to home healthcare or frequent doctor’s office visits
for follow-up further increasing the patient exposure to healthcare. There is also an
increase in the use of broad spectrum antibiotics. [15, 35] This increases the selec-
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tive pressure of Staphylococcus aureus and other bacteria and leads to increases in
antimicrobial resistance. [15, 35]
Currently, the medical definition of CA-MRSA is any outpatient isolate or an
inpatient isolate that is cultured within 48 to 72 hours of admission to a hospital.
This definition needs to modified to take into account many of the predisposing risk
factors so a more accurate prevalence of true CA-MRSA can be assessed. This can
be done by altering the definition of nosocomial MRSA to include patients with these
risk factors. A term of healthcare associated MRSA could be utilized instead of
nosocomial. [18] This would result in the term CA-MRSA being utilized only for
patients with MRSA and no predisposing risk factors.
There was also an article recently published on the BBC News website that sug-
gested that MRSA may be carried by pets. [36] There was no suggestion as to how
the animals acquired the infection. [36] Cats, dogs, and rabbits all tested positive for
colonization of MRSA. [36] This article is another reason why there is a need for more
studies on MRSA and the risk factors associated with its transmission. [36]
There should also be more intensive studies focused in the areas of daycare centers
and the possible spread of CA-MRSA and the role of household contacts in the spread
of CA-MRSA. Some studies have suggested a link between CA-MRSA and daycare
centers. [32, 31] These studies found nothing statistically significant to suggest that
daycare played a role in the spread of the infection. [32, 31] There were no studies that
solely focused on the role of household contacts and CA-MRSA in children. Another
aspect that merits further study is the relationship between parents’ or caregivers’
occupation and MRSA infection. It has been hypothesized that parents who work in
the healthcare industry are likely to be colonized with MRSA and as a result colonize
their children. [2, 22] This would increase the likelihood of the children to develop an
MRSA infection. If these studies are carried out we may find a better way to predict
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patients that may have MRSA and therefore start adequate treatment more quickly
and prevent children from dying.
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